[{"source": "benzinga", "link": "https://www.benzinga.com/markets/cannabis/22/03/26007152/exclusive-ginger-shoutem-partner-to-offer-direct-to-consumer-apps-to-cannabis-retailers", "title": "EXCLUSIVE: Ginger, Shoutem Partner To Offer Direct-To-Consumer Apps To Cannabis Retailers", "date": "2022-03-05 12:53", "summary": "Ginger [Commerce], a California pure-play, direct-to-consumer platform, launched an exclusive partnership with Shoutem, Benzinga has learned exclusively.\n\nGinger and Shoutem are now creating iOS native, white-labeled mobile apps exclusively for Ginger\u2019s customer brands.", "tickers": ["AAPL"], "sentiments": [0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"EXCLUSIVE: Ginger, Shoutem Partner To Offer Direct-To-Consumer Apps To Cannabis Retailers. Ginger [Commerce], a California pure-play, direct-to-consumer platform, launched an exclusive partnership with Shoutem, Benzinga has learned exclusively.\n\nGinger and Shoutem are now creating iOS native, white-labeled mobile apps exclusively for Ginger\u2019s customer brands.\"\n\nStock Prediction(s) for AAPL:", "Prediction": "\n- Apple Inc. (NASDAQ: AAPL) will increase because they are a direct competitor of Shoutem and they have a lot of money to invest in this market.\n- Shoutem will decrease because they are a direct competitor of Apple and they do not have the same resources."}, {"source": "benzinga", "link": "https://www.benzinga.com/news/22/03/26007436/barrons-latest-picks-and-pans-meta-zendesk-tesla-unitedhealth-group-and-more", "title": "Barron's Latest Picks And Pans: Meta, Zendesk, Tesla, UnitedHealth Group And More", "date": "2022-03-05 16:08", "summary": "This weekend&#39;s Barron&#39;s cover story celebrates Women&#39;s History Month by\u00a0highlighting the women\u00a0who are shaping U.S. finance, and navigating the nation&#39;s biggest companies through turbulent times.", "tickers": ["FB", "TSLA", "UNH", "ZEN"], "sentiments": [0, 0, 0, 0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"Barron's Latest Picks And Pans: Meta, Zendesk, Tesla, UnitedHealth Group And More. This weekend&#39;s Barron&#39;s cover story celebrates Women&#39;s History Month by\u00a0highlighting the women\u00a0who are shaping U.S. finance, and navigating the nation&#39;s biggest companies through turbulent times.\"\n\nStock Prediction(s) for FB, TSLA, UNH, ZEN:", "Prediction": "\n- Facebook, Inc. (NASDAQ: FB) will increase because they are highlighted in Barron's as a company that is being steered by women and is doing well in turbulent times.\n- Tesla, Inc. (NASDAQ: TSLA) will increase because they are highlighted in Barron's as a company that is being steered by women and is doing well in turbulent times.\n- UnitedHealth Group Inc (NYSE: UNH) will increase because they are highlighted in Barron's as a company that is being steered by women and is doing well in turbulent times.\n- Zendesk, Inc. (NYSE:"}, {"source": "benzinga", "link": "https://www.benzinga.com/general/entertainment/22/03/25982591/10-weirdest-mrbeast-videos", "title": "10 Weirdest MrBeast Videos", "date": "2022-03-05 14:23", "summary": "This year marks the tenth anniversary of the arrival of Jimmy Donaldson on Alphabet Inc.&#39;s (NASDAQ: GOOG) (NASDAQ: GOOGL) YouTube video platform.", "tickers": ["GOOG", "GOOGL", "MCD", "NFLX", "WMT"], "sentiments": [0, 0, 0, 0, 0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"10 Weirdest MrBeast Videos. This year marks the tenth anniversary of the arrival of Jimmy Donaldson on Alphabet Inc.&#39;s (NASDAQ: GOOG) (NASDAQ: GOOGL) YouTube video platform.\"\n\nStock Prediction(s) for GOOG, GOOGL, MCD, NFLX, WMT:", "Prediction": "\n- Alphabet Inc. (NASDAQ: GOOG) (NASDAQ: GOOGL) will increase because of Jimmy Donaldson's (MrBeast) anniversary videos.\n- McDonald's Corporation (NYSE: MCD) will increase because of Jimmy Donaldson's (MrBeast) anniversary videos.\n- Netflix, Inc. (NASDAQ: NFLX) will increase because of Jimmy Donaldson's (MrBeast) anniversary videos.\n- Walmart Inc. (NYSE: WMT) will increase because of Jimmy Donaldson's (MrBeast) anniversary videos."}, {"source": "benzinga", "link": "https://www.benzinga.com/general/education/22/03/26007476/if-you-invested-100-in-tesla-when-elon-musk-was-sued-by-the-sec-for-securities-fraud-in-2018-he", "title": "Here's How Much You'd Have Right Now If You Invested $100 In Tesla When Elon Musk Was Sued By The SEC In 2018", "date": "2022-03-05 17:12", "summary": "Investors who placed their hard-earned cash into major US indices have enjoyed respectable returns since fall 2018.", "tickers": ["DIA", "QQQ", "SPY", "TSLA"], "sentiments": [0, 0, 0, 0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"Here's How Much You'd Have Right Now If You Invested $100 In Tesla When Elon Musk Was Sued By The SEC In 2018. Investors who placed their hard-earned cash into major US indices have enjoyed respectable returns since fall 2018.\"\n\nStock Prediction(s) for DIA, QQQ, SPY, TSLA:", "Prediction": "\n- The Dow Jones Industrial Average (NYSEARCA: DIA) will increase because Tesla is a major component of the index.\n- The Nasdaq-100 Index (NASDAQ: QQQ) will increase because Tesla is a major component of the index.\n- The S&P 500 Index (NYSEARCA: SPY) will increase because Tesla is a major component of the index.\n- Tesla, Inc. (NASDAQ: TSLA) will increase because they are a major component of the indices, and they have had a good year."}, {"source": "benzinga", "link": "https://www.benzinga.com/markets/cryptocurrency/22/03/26007375/if-you-invested-100-in-bitcoin-ethereum-and-dogecoin-at-the-bottom-of-us-markets-in-2020-h", "title": "If You Invested $100 In Bitcoin, Ethereum And Dogecoin At The Bottom Of US Markets In 2020, Here's How Much You'd Have Now", "date": "2022-03-05 15:28", "summary": "Investors who have put money into major US indices have enjoyed respectable returns since the bottom of the market on Mar. 23, 2020.", "tickers": ["BTCUSD", "DIA", "DOGEUSD", "ETHUSD", "QQQ", "SPY"], "sentiments": [0, 0, 0, 0, 0, 0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"If You Invested $100 In Bitcoin, Ethereum And Dogecoin At The Bottom Of US Markets In 2020, Here's How Much You'd Have Now. Investors who have put money into major US indices have enjoyed respectable returns since the bottom of the market on Mar. 23, 2020.\"\n\nStock Prediction(s) for BTCUSD, DIA, DOGEUSD, ETHUSD, QQQ, SPY:", "Prediction": "\n- Bitcoin (BTCUSD) will increase because it is the first and most well-known cryptocurrency.\n- The Dow Jones Industrial Average (DIA) will increase because it is a major US index.\n- Ethereum (ETHUSD) will increase because it is the second-largest cryptocurrency.\n- Dogecoin (DOGEUSD) will increase because it is a lesser-known cryptocurrency that has had a recent surge in price.\n- The Nasdaq-100 Index (QQQ) will increase because it is a major US index.\n- The S&P 500 Index (SPY) will increase because"}, {"source": "benzinga", "link": "https://www.benzinga.com/news/22/03/26006820/hate-to-say-it-but-we-need-to-do-this-immediately-teslas-elon-musk-says-on-twitter", "title": "'Hate To Say It' But We Need to Do This 'Immediately': Tesla's Elon Musk Says On Twitter", "date": "2022-03-05 12:42", "summary": "Tesla, Inc. (NASDAQ: TSLA) CEO Elon Musk on Friday made a puzzling plea on Twitter regarding non-renewable sources of energy.", "tickers": ["TSLA"], "sentiments": [0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"'Hate To Say It' But We Need to Do This 'Immediately': Tesla's Elon Musk Says On Twitter. Tesla, Inc. (NASDAQ: TSLA) CEO Elon Musk on Friday made a puzzling plea on Twitter regarding non-renewable sources of energy.\"\n\nStock Prediction(s) for TSLA:", "Prediction": "\n- Tesla, Inc. (NASDAQ: TSLA) will decrease because their CEO is tweeting about something that is not related to the company."}, {"source": "benzinga", "link": "https://www.benzinga.com/news/22/03/26006727/elon-musk-says-he-is-a-free-speech-absolutist-after-refusing-to-block-russian-new-sources-on-starlin", "title": "Elon Musk Says He Is A 'Free Speech Absolutist' After Refusing To Block Russian New Sources On Starlink", "date": "2022-03-05 11:24", "summary": "Elon Musk has invariably come across as a person who speaks his mind, and on Friday, the Tesla, Inc. (NASDAQ: TSLA) CEO made his viewpoint clear on the topic of\u00a0censorship.", "tickers": ["TSLA"], "sentiments": [0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"Elon Musk Says He Is A 'Free Speech Absolutist' After Refusing To Block Russian New Sources On Starlink. Elon Musk has invariably come across as a person who speaks his mind, and on Friday, the Tesla, Inc. (NASDAQ: TSLA) CEO made his viewpoint clear on the topic of\u00a0censorship.\"\n\nStock Prediction(s) for TSLA:", "Prediction": "\n- Tesla, Inc. (NASDAQ: TSLA) will increase because Elon Musk is a \"free speech absolutist\" and will not block Russian new sources on Starlink."}, {"source": "benzinga", "link": "https://www.benzinga.com/trading-ideas/22/03/26007193/how-much-1-000-invested-in-ford-when-it-unveiled-ford-plan-in-mid-2021-will-be-worth-now", "title": "How Much $1,000 Invested In Ford When It Unveiled Ford+ Plan In Mid-2021 Would Be Worth Now", "date": "2022-03-05 14:05", "summary": "Ford Motor Company (NYSE: F) has been proactively pursuing an electrification strategy, and this has helped the company edge ahead of fellow legacy automakers.", "tickers": ["F"], "sentiments": [0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"How Much $1,000 Invested In Ford When It Unveiled Ford+ Plan In Mid-2021 Would Be Worth Now. Ford Motor Company (NYSE: F) has been proactively pursuing an electrification strategy, and this has helped the company edge ahead of fellow legacy automakers.\"\n\nStock Prediction(s) for F:", "Prediction": "\n- Ford Motor Company (NYSE: F) will continue to increase because they are ahead of the competition in the electrification race, and this will help them edge out other legacy automakers."}, {"source": "benzinga", "link": "https://www.benzinga.com/trading-ideas/long-ideas/22/03/26006916/warren-buffetts-berkshire-hathaway-boosts-stake-in-this-oil-company", "title": "Warren Buffett's Berkshire Hathaway Boosts Stake In This Oil Company", "date": "2022-03-05 10:57", "summary": "The Russo-Ukrainian conflict has led to a sharp rally in crude oil prices and as an extension in stocks of oil and gas manufacturers as well.", "tickers": ["BRK-B", "OXY"], "sentiments": [0, 0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"Warren Buffett's Berkshire Hathaway Boosts Stake In This Oil Company. The Russo-Ukrainian conflict has led to a sharp rally in crude oil prices and as an extension in stocks of oil and gas manufacturers as well.\"\n\nStock Prediction(s) for BRK-B, OXY:", "Prediction": "\n- Berkshire Hathaway Inc. (NYSE: BRK-B) will increase because they have a stake in an oil company that is benefiting from the Russo-Ukrainian conflict.\n- Occidental Petroleum Corporation (NYSE: OXY) will increase because they have a stake in an oil company that is benefiting from the Russo-Ukrainian conflict."}, {"source": "benzinga", "link": "https://www.benzinga.com/news/22/03/26006800/latest-on-russia-ukraine-war-paypal-suspends-service-in-russia-ceasefire-violated", "title": "Latest On Russia-Ukraine War: Paypal Suspends Service In Russia; Ceasefire Violated", "date": "2022-03-05 09:33", "summary": "PayPal Holdings Inc. (NASDAQ: PYPL) on Saturday announced that it is halting its operations in Russia, joining a growing number of companies responding to the Ukrainian invasion.\u00a0", "tickers": ["MA", "PINS", "PYPL", "RELY", "V"], "sentiments": [0, 0, 0, 0, 0], "blurb": "News: \"AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials. U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval. Researchers hope will result in the start of widespread vaccinations by the end of the year.\"\n\nStock Prediction(s) for AZN, JNJ, PFE, MRNA:\n- AstraZeneca plc (NASDAQ: AZN) will increase because their vaccine is 90% effective, and they are only waiting for regulatory approval before being deployed.\n- Johnson & Johnson (NYSE: JNJ) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Pfizer Inc (NYSE: PFE) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n- Moderna Inc (NASDAQ: MRNA) will decrease because they are also working on a vaccine, but they are a direct competitor of AstraZeneca.\n\nNews: \"Latest On Russia-Ukraine War: Paypal Suspends Service In Russia; Ceasefire Violated. PayPal Holdings Inc. (NASDAQ: PYPL) on Saturday announced that it is halting its operations in Russia, joining a growing number of companies responding to the Ukrainian invasion.\u00a0\"\n\nStock Prediction(s) for MA, PINS, PYPL, RELY, V:", "Prediction": "\n- Mastercard Inc (NYSE: MA) will increase because they are a direct competitor of PayPal, and PayPal is suspending their operations in Russia.\n- Pinterest Inc (NYSE: PINS) will increase because they are a direct competitor of PayPal, and PayPal is suspending their operations in Russia.\n- PayPal Holdings Inc. (NASDAQ: PYPL) will decrease because they are suspending their operations in Russia.\n- The RealReal Inc (NASDAQ: RELY) will increase because they are a direct competitor of PayPal, and PayPal is suspending their operations in Russia.\n- Visa Inc (NYSE: V) will"}]